hexadecanyl-1,3-propanediol | 66359-38-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: hexadecanyl-1,3-propanediol
• 英文别名: 1,3-nonadecanediol；Hexadecyl-propane-1,3-diol；nonadecane-1,3-diol
• CAS: 66359-38-4
• 化学式: C₁₉H₄₀O₂
• 分子量: 300.525
• InChiKey: RSEXBRKIOMNOPQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.6
• 重原子数：
  21
• 可旋转键数：
  17
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• 1,3-FATTY DIOL COMPOUNDS AND DERIVATIVES THEREOF
  申请人：REG Life Sciences LLC

  公开号：US20180072645A1

  公开（公告）日：2018-03-15

  The disclosure relates to the field of specialty chemicals. In particular, the disclosure provides novel 1,3-fatty-diol compounds and derivatives thereof which are useful e.g., in the production of personal care products, surfactants, detergents, polymers, paints, coatings, and as emulsifiers, emollients, and thickeners in cosmetics and foods, as industrial solvents and plasticizers, etc.

  本公开涉及专业化学领域。具体而言，本公开提供了新颖的1,3-脂肪二醇化合物及其衍生物，可用于个人护理产品、表面活性剂、洗涤剂、聚合物、涂料、涂层的生产，以及作为化妆品和食品中的乳化剂、润肤剂和增稠剂，工业溶剂和增塑剂等。
• Phosphonate compounds
  申请人：Hostetler Y. Karl

  公开号：US20050176673A1

  公开（公告）日：2005-08-11

  The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.

  本发明涉及膦酸盐化合物、含有它们的组合物、获得它们的方法，以及它们用于治疗多种医学疾病，例如骨质疏松症和其他骨代谢障碍、癌症、病毒感染等。
• PHOSPHONATE COMPOUNDS
  申请人：Hostetler Y. Karl

  公开号：US20080103115A1

  公开（公告）日：2008-05-01

  The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.

  本发明涉及磷酸酯化合物、含有它们的组合物、制备它们的方法以及它们用于治疗各种医学疾病，例如骨质疏松症和其他骨代谢紊乱、癌症、病毒感染等。
• Phosphonate Compounds
  申请人：THE REGENTS OF THE UNIVERSITY OF CALIF

  公开号：US20130045950A1

  公开（公告）日：2013-02-21

  The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g., osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.

  本发明涉及磷酸酯化合物、含有它们的组合物、制备它们的过程以及它们用于治疗各种医学疾病，例如骨质疏松症和其他骨代谢紊乱、癌症、病毒感染等。
• Phosphonate ester antiviral compounds
  申请人：The Regents of The University of California at San Diego

  公开号：EP1914237A2

  公开（公告）日：2008-04-23

  The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of medical disorders, e.g. osteoporosis and other disorders of bone metabolism, cancer, viral infections, and the like.

  本发明涉及膦酸盐化合物、含有膦酸盐化合物的组合物、获得膦酸盐化合物的工艺，以及膦酸盐化合物在治疗各种疾病方面的用途，例如骨质疏松症和其他骨代谢紊乱、癌症、病毒感染等。